Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haixiao Zhang

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Frontiers in Immunology|July 21, 2025
Impact of pre-transplant body mass index on outcomes in AML patients aged ≥ 50 years after allogeneic hematopoietic cell transplantationWenwen Guo, Haixiao Zhang, Hongye Gao, et al.
Experimental Hematology & Oncology|February 15, 2024
Outcomes of acute myeloid leukemia patients undergoing allogeneic hematopoietic stem cell transplantation: validation, comparison and improvement of 2022 ELN genetic risk systemHaixiao Zhang, Xinhui Zheng, Wenwen Guo, et al.
Annals of Hematology|October 25, 2023
Efficacy of venetoclax combined with decitabine conditioning regimen for allogeneic hematopoietic stem cell transplantation in high-risk and elderly patients with myeloid neoplasmsXinhui Zheng, Hongye Gao, Ni Lu, et al.
Annals of Hematology|July 5, 2024
WT1 gene mutations impact post-transplant relapse in myelodysplastic syndrome with excess blasts 2 patientsWenwen Guo, Haixiao Zhang, Mingyang Wang, et al.
Blood Science (Baltimore, Md.)|August 12, 2022
Risk factors associated with hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantationBiao Shen, Yueshen Ma, Haixiao Zhang, et al.
Bone Marrow Transplantation|August 27, 2024
Impact of bone marrow fibrosis on outcomes of allogeneic hematopoietic stem cell transplantation in acute myeloid leukemiaHaixiao Zhang, Wenwen Guo, Jiali Wang, et al.
Cell Death & Disease|March 28, 2026
Th17-driven CD8<sup>+</sup> T cells in hUC-MSC and CAR T-cell dual immunotherapy for superior anti-tumor efficacyCaidong Hu, Haixiao Zhang, Haojie Zhu, et al.
Hematological Oncology|September 27, 2023
Comparison of autologous, matched sibling, and alternative donor stem cell transplant outcomes for acute myeloid leukemia patients in first remission: A propensity score matching studyMingyang Wang, Haixiao Zhang, Xinhui Zheng, et al.
Infection and Drug Resistance|March 13, 2023
Development of a Risk Prediction Model of Subsequent Bloodstream Infection After Carbapenem-Resistant Enterobacteriaceae Isolated from Perianal Swabs in Hematological PatientsJia Liu, Haixiao Zhang, Dan Feng, et al.
Bone Marrow Transplantation|May 14, 2026
CBFB::MYH11 MRD after the second chemotherapy cycle: a guide for allogeneic transplantation in favorable-risk AMLMingyang Wang, Guangji Zhang, Wenwen Guo, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Frontiers in Immunology|July 21, 2025
Impact of pre-transplant body mass index on outcomes in AML patients aged ≥ 50 years after allogeneic hematopoietic cell transplantationWenwen Guo, Haixiao Zhang, Hongye Gao, et al.
Experimental Hematology & Oncology|February 15, 2024
Outcomes of acute myeloid leukemia patients undergoing allogeneic hematopoietic stem cell transplantation: validation, comparison and improvement of 2022 ELN genetic risk systemHaixiao Zhang, Xinhui Zheng, Wenwen Guo, et al.
Annals of Hematology|October 25, 2023
Efficacy of venetoclax combined with decitabine conditioning regimen for allogeneic hematopoietic stem cell transplantation in high-risk and elderly patients with myeloid neoplasmsXinhui Zheng, Hongye Gao, Ni Lu, et al.
Annals of Hematology|July 5, 2024
WT1 gene mutations impact post-transplant relapse in myelodysplastic syndrome with excess blasts 2 patientsWenwen Guo, Haixiao Zhang, Mingyang Wang, et al.
Blood Science (Baltimore, Md.)|August 12, 2022
Risk factors associated with hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantationBiao Shen, Yueshen Ma, Haixiao Zhang, et al.
Bone Marrow Transplantation|August 27, 2024
Impact of bone marrow fibrosis on outcomes of allogeneic hematopoietic stem cell transplantation in acute myeloid leukemiaHaixiao Zhang, Wenwen Guo, Jiali Wang, et al.
Cell Death & Disease|March 28, 2026
Th17-driven CD8<sup>+</sup> T cells in hUC-MSC and CAR T-cell dual immunotherapy for superior anti-tumor efficacyCaidong Hu, Haixiao Zhang, Haojie Zhu, et al.
Hematological Oncology|September 27, 2023
Comparison of autologous, matched sibling, and alternative donor stem cell transplant outcomes for acute myeloid leukemia patients in first remission: A propensity score matching studyMingyang Wang, Haixiao Zhang, Xinhui Zheng, et al.
Infection and Drug Resistance|March 13, 2023
Development of a Risk Prediction Model of Subsequent Bloodstream Infection After Carbapenem-Resistant Enterobacteriaceae Isolated from Perianal Swabs in Hematological PatientsJia Liu, Haixiao Zhang, Dan Feng, et al.
Bone Marrow Transplantation|May 14, 2026
CBFB::MYH11 MRD after the second chemotherapy cycle: a guide for allogeneic transplantation in favorable-risk AMLMingyang Wang, Guangji Zhang, Wenwen Guo, et al.
Pageof 4